Please provide your email address to receive an email when new articles are posted on . Among patients with HF with reduced ejection fraction, elevated N-terminal pro-B-type natriuretic peptide level ...

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center Mortality goes up in tandem with admission natriuretic peptide levels in patients with severe ...

Beta-blockers and other cardiovascular medications did not have any significant effect on mortality risk in patients with elevated N-terminal pro-brain-type natriuretic peptide (NT-proBNP) and without ...

Patients with moderately symptomatic heart failure (HF) and elevated levels of NT-proBNP, but no recent HF hospitalization, see significant clinical and quality-of-life benefits from pulmonary artery ...

Blood pressure cuff Elevated NT-proBNP may represent a useful biomarker for the identification of individuals at high risk for CVD and mortality across the spectrum of blood and pulse pressures.

Adults with hypertension who have prediabetes and subclinical myocardial injury or stress face a higher risk of incident ...

NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most sign ...

Healthy people - especially women - with elevated levels of the heart failure marker NT-proBNP have a lower risk of developing type 2 diabetes. However, if these people develop diabetes nonetheless, ...

Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.